Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2091]
News [6479]
Articles [133]
Editorials [5]
Conferences [171]
elearning [10]
Future perspective of CDH1 mutation in gastric and breast cancers
Dr. Giovanni Corso - University of Milan, Italy, Meeting president
Future perspective of CDH1 mutation in gastric and breast cancers ( Dr. Giovanni Corso - University of Milan, Italy, Meeting president )
22 Jul 2020
Prophylactic gastrectomy in CDH1 mutation
Prof. Franco Roviello - University of Siena, Italy
Prophylactic gastrectomy in CDH1 mutation ( Prof. Franco Roviello - University of Siena, Italy )
22 Jul 2020
Pathology of diffuse gastric cancer with CDH1 mutation
Prof. Fàtima Carneiro - University of Porto, Portugal
Pathology of diffuse gastric cancer with CDH1 mutation ( Prof. Fàtima Carneiro - University of Porto, Portugal )
22 Jul 2020
Why the ADAURA study is a big step forward for NSCLC
Dr Luis Raez - Memorial Cancer Institute, Florida, USA
Why the ADAURA study is a big step forward for NSCLC ( Dr Luis Raez - Memorial Cancer Institute, Florida, USA )
17 Jul 2020
Association of gene expression with clinical outcomes in RCC patients treated...
Prof Scott Tykodi - University of Washington, Seattle, USA
Association of gene expression with clinical outcomes in RCC patients treated with pembrolizumab ( Prof Scott Tykodi - University of Washington, Seattle, USA )
14 Jul 2020
DELIVER: Investigating the efficacy of nivolumab treatment in gastric cancer
Prof Yu Sunakawa - St. Marianna University School of Medicine, Kawasaki, Japan
DELIVER: Investigating the efficacy of nivolumab treatment in gastric cancer ( Prof Yu Sunakawa - St. Marianna University School of Medicine, Kawasaki, Japan )
13 Jul 2020
Venetoclax plus navitoclax in R/R ALL and lymphoblastic lymphoma
Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA
Venetoclax plus navitoclax in R/R ALL and lymphoblastic lymphoma ( Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA )
3 Jul 2020
Meet the Expert: Daniel Seymour
Daniel Seymour - BIO Ventures for Global Health, Seattle, USA
Meet the Expert: Daniel Seymour ( Daniel Seymour - BIO Ventures for Global Health, Seattle, USA )
1 Jul 2020
Gut microbiome disturbance by antibiotic treatment early in life is sufficient...
Dr Carolina Vicente-Dueñas - Institute of Biomedical Research of Salamanca...
Gut microbiome disturbance by antibiotic treatment early in life is sufficient to induce leukaemia in predisposed mice ( Dr Carolina Vicente-Dueñas - Institute of Biomedical Research of Salamanca, Salamanca, Spain )
30 Jun 2020
COMBI-AD trial: Adjuvant dabrafenib plus trametinib in patients with resected...
Prof Axel Hauschild - University Hospital, Schleswig-Holstein, Germany
COMBI-AD trial: Adjuvant dabrafenib plus trametinib in patients with resected stage III BRAF V600–mutant melanoma ( Prof Axel Hauschild - University Hospital, Schleswig-Holstein, Germany )
30 Jun 2020
IMvigor130: Atezolizumab with or without chemotherapy in metastatic urothelial...
Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA
IMvigor130: Atezolizumab with or without chemotherapy in metastatic urothelial cancer ( Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA )
30 Jun 2020
Checkmate 9LA: Nivolumab, ipilimumab and chemotherapy for stage IV NSCLC
Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany
Checkmate 9LA: Nivolumab, ipilimumab and chemotherapy for stage IV NSCLC ( Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany )
30 Jun 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation